Andrea Attanasio

Andrea Attanasio

Auto-generated profile, based on publicly available information

Andrea Attanasio

Universitary Cardiology Department, IRCCS Policlinico San Donato, Milan, Italy (G.G., A.A.).

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
PMPaolo Milani
Paolo Milani
GSGiuseppe Damiano Sanna
Giuseppe Damiano Sanna
RMRoberta Mussinelli
Roberta Mussinelli
MBMarco Basset
Marco Basset
GGGianluigi Guida
Gianluigi Guida
Giovanni PalladiniGiovanni Palladini
Giovanni Palladini
Background: For the time being, tafamidis is the only approved treatment for wild‐type transthyretin cardiac amyloidosis. However, benefits on all‐cause death only emerge after ≈18 months. The current available staging systems are unable to specifically discriminate patients at high risk of death within 18 months from diagnosis, and the selection of patients who are expected to benefit from tafamidis is left to the clinical judgment of treating physicians, being often based primarily (and sometimes only) on age. We searched baseline variables able to discriminate patients at risk of death within 18 months. Methods and Results: We randomly divided our prospectively maintained database in 2 cohorts, a testing (two thirds) and a validating (one third) set, respectively. We used the Eastern Cooperative Oncology Group–Performance Status as a simple scoring of frailty. We analyzed the clinical, laboratory and instrumental features of 691 consecutive wild‐type transthyretin cardiac amyloidosis patients diagnosed between 2006 and 2021. Median follow‐up was 43 months, and 367 patients (53%) died. Eighteen‐month death was predicted by NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide; cutoff 4200 ng/L), cardiac troponin I (cutoff 92 ng/L), and age (cutoff 80 years). At multivariable analysis, Eastern Cooperative Oncology Group–Performance Status >1 along with the selected variables were independent prognostic determinants and outperformed New York Heart Association functional class. The combination of these variables identified standard‐ and high‐risk patients (all variables above the cutoffs) with a median survival of 57 and 17 months, respectively ( P <0.001). This was confirmed in the validation set. Conclusions: A simple scoring system including age, cardiac biomarkers, and Eastern Cooperative Oncology Group–Performance Status identifies subjects with cardiac wild‐type transthyretin cardiac amyloidosis at high risk of early death.

21 February 2024 in European Journal of Preventive Cardiology
Verified
Journal Article
Closed access
PDF file
AAAndrea Attanasio
Andrea Attanasio
LTLara Tondi
Lara Tondi
SCserenella castelvecchio
serenella castelvecchio
VPVittorio Pazzanese
Vittorio Pazzanese
APAnna Palmisano
Anna Palmisano
PCPaolo G Camici
Paolo G Camici
Andrea Attanasio, Lara Tondi, Serenella Castelvecchio, Vittorio Pazzanese, Anna Palmisano, Antonio Esposito, Pietro Ameri, Claudia Canale, Alberto Cappelletti,

5 February 2024 in European Journal of Preventive Cardiology
Verified
Journal Article
Open access
PDF file
AAAndrea Attanasio
Andrea Attanasio
GGGianluigi Guida
Gianluigi Guida
GDGiandomenico Disabato
Giandomenico Disabato
MPMassimo F Piepoli
Massimo F Piepoli
Andrea Attanasio, MD, Gianluigi Guida, MD, Giandomenico Disabato, MD, Massimo F Piepoli, MD, PhD, FESC, FHFA; Lifestyle intervention on left atrium size and fun

15 October 2026 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Open access
PDF file
MRMauro Lo Rito
Mauro Lo Rito
MSMattia Squillace
Mattia Squillace
MAMauro Luca Agnifili
Mauro Luca Agnifili
ARAntonio Rosato
Antonio Rosato
SASerena Anglese
Serena Anglese
Francesco BedogniFrancesco Bedogni
Francesco Bedogni
Background: Anomalous Aortic Origin of a Coronary Artery (AAOCA) high‐risk anatomical features (intramural segment, acute take‐off angle, slit‐like ostium) cause coronary stenosis leading to myocardial infarction. How these features alter coronary physiology remains unclear. Aims: We aimed to evaluate their impact on coronary blood supply using continuous thermodilution. Methods: We prospectively enrolled 51 AAOCA patients undergoing continuous thermodilution. Subjects were classified into an ischemic risk (IR) group (intramural segment, acute angle, oval or slit ostium) or non‐ischemic risk (no‐IR) group. Non‐anomalous coronary arteries served as controls. We measured absolute coronary blood flow (CBF) and microvascular resistance. Results: Subjects (median age 48.4 years) presented mostly with angina, syncope, and arrhythmia. Final analysis included 48 AAOCA cases (31 IR, 17 no‐IR) and 45 controls. The IR group had a median IM length of 9 mm, take‐off angle of 31.9°, and a slit‐like or oval ostium. The no‐IR group had a median angle of 51.5° and an oval or round ostium. At rest, absolute CBF and microvascular resistance showed no significant differences among groups. However, during hyperemia, the IR group had significantly reduced CBF compared to controls (179 vs. 290 mL/min, p = 0.015). The IR group demonstrated higher microvascular resistance at rest (1473 vs. 1150, p = 0.024) and during hyperemia (433 vs. 305, p = 0.012), indicating persistently increased coronary vascular tone. Conclusions: High‐risk anatomical features of AAOCA are associated with altered coronary physiology. An intramural segment, acute take‐off angle, and slit‐like or oval ostium are linked to reduced hyperemic coronary blood flow due to increased microvascular resistance.

1 June 2025 in Circulation: Cardiovascular Imaging
Verified
Journal Article
Closed access
SCStefano Censi
Stefano Censi
GAGiada De Angeli
Giada De Angeli
FPFederico Pieruzzi
Federico Pieruzzi
LTLara Tondi
Lara Tondi
GGGianluigi Guida
Gianluigi Guida
ACAntonia Camporeale
Antonia Camporeale

18 May 2024
Verified
Conference Paper
Closed access
PMPaolo Milani
Paolo Milani
GDGiuseppe Damiano
Giuseppe Damiano
RMRoberta Mussinelli
Roberta Mussinelli
MBMarco Basset
Marco Basset
PBPietro Benvenuti
Pietro Benvenuti
Giovanni PalladiniGiovanni Palladini
Giovanni Palladini
**Author Listing - Lead/ Submitting Author (we will be communicating with this individual): Name, Institution, City and State where the work was | POSTER